Advertisement

Angiogenesis pp 125-134 | Cite as

Regulation of Angiogenesis: The Role of Protein Kinase, Nitric Oxide, Thrombin and Basement Membrane Synthesis

  • M. E. Maragoudakis
  • N. E. Tsopanoglou
  • G. C. Haralabopoulos
  • E. Sakkoula
  • E. Pipili-Synetos
  • E. Missirlis
Chapter
Part of the NATO ASI Series book series (NSSA, volume 263)

Abstract

Angiogenesis plays a key role in the pathology of many disease states (Folkman and Shing, 1992). Practically every medical specialty deals with disease states where a derangement of angiogenesis is evident. In addition, angiogenesis is a prominent event in many physiological processes such as the establishment of placenta, the changes in the mammary gland during lactation and in the endometrium during ovulation (Auerbach et al., 1991). Angiogenesis is also important in wound healing and repair processes (Knighton et al., 1990).

Keywords

Nitric Oxide Titanocene Dichloride Blood Clotting Cascade Physiological Angiogenesis Angiogenic Cascade 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Auerbach, R., Auerbach, W., and Polakowski, I., 1991, Assays for angiogenesis: A review, Pharmac. Therap. 51: 1–11.CrossRefGoogle Scholar
  2. Bastaki, M., Missirlis, E., Klouras, N., Karakiulakis, G., and Maragoudakis, M., 1994, Eur. J. Pharmacol. (in press).Google Scholar
  3. Folkman, J., 1985, Towards an understanding of angiogenesis: Seach and discovery, Persp. in Biol. and Med. 29:10–35.Google Scholar
  4. Folkman, J., Szabo, S., Storroff, M., McNeil, P., Li, W., and Shing, Y., 1991, Duodenal ulcer: Discovery of a new mechanism and development of angiogenic therapy that accelerates healing, Ann. of Surg. 214: 414–426.CrossRefGoogle Scholar
  5. Folkman, J., and Shing, Y., 1992, Angiogenesis: a mini review, J. Biol. Chem. 267: 10931–10933.PubMedGoogle Scholar
  6. Good, D.J., Polverini, P.J., Rastinejad, F., LeBeau, M.M., Lemons, R.S., Frazier, W.A., and Bouck, N.P., 1990, A tumor suppressor-dependent inhibitor of angiogenesis is immunoligically and functionally indistinguishable from a fragment of thrombospondin., Proc. Natl. Acad. Sci. USA 87: 6624–6628.PubMedCrossRefGoogle Scholar
  7. Grant, D.S., Tashiro, K.I., Segui-Real, B., Yamada, Y., Martin, G.R., and Kleinman, H., 1989, Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro, Cell 58: 933–943.PubMedCrossRefGoogle Scholar
  8. Gullino, P.M., 1981, Angiogenesis and Neoplasia, New Engl. J. Med. 305: 884–885.PubMedCrossRefGoogle Scholar
  9. Gullino, P.M., 1992, On promoters of angiogenesis and therapeutic potential, in “Angiogenesis in Health and Diseases”, M.E. Maragoudakis, P. Gullino and P. I. Lelkes, eds., Plenum Press, pp. 287–294.CrossRefGoogle Scholar
  10. Harris-Hooker, S.A., Gajdusek, C.M., Wight, T.N., and Schwartz, S.M., 1983, Neovascular response induced by cultured aortic endothelial cells, J. Cell Physiol. 114: 302–310.PubMedCrossRefGoogle Scholar
  11. Houslay, M.D., 1991, Crosstalk: a pivotal role of protein kinase C in modulating relationships between signal transduction pathways, Eur. J. Biochem. 195: 9–27.PubMedCrossRefGoogle Scholar
  12. Knighton, D.R., Hunt, T.K., Thakral, K.K. and Goodson, W.H., 1982, Role of platelets and fibrin in the healing sequence: An in vivo study of angiogenesis and collagen synthesis, Annals of Surgery 196: 379–388.PubMedCrossRefGoogle Scholar
  13. Knighton, D.R., Phillips, G.D., and Fiegel, V.D., 1990, Wound healing angiogenesis: Indirect stimulation of basic fibroblast growth factor, J. Trauma 30 (suppl. 12): S134–5144.PubMedCrossRefGoogle Scholar
  14. Konerding, M.A., van Ackern, C., Steinberg, F., Streffer, C., 1992, The development of the tumor vascular system: 2D and 3D approaches to network formation in Human xenografted tumors, in: “Angiogenesis in Health and Diseases”, M.E. Maragoudakis, P. Gullino and P. I. Lelkes, eds., Plenum Press, pp. 173.CrossRefGoogle Scholar
  15. Madri, J.A., Bell, L., Marx, M., Merwin, J.R., Basson, C., and Prinz, C, 1991, Effects of soluble factors and extracellular matrix components on vascular cell behavior in vitro and in vivo: Models of de-endothelialization and repair, J. Cellul. Biochem. 45: 123–130.CrossRefGoogle Scholar
  16. Maragoudakis, M.E., Panoutsacopoulou, M. and Sarmonika M., 1988, Rate of basement membrane synthesis as an index of angiogenesis, Tissue and Cell 20: 531–539.PubMedCrossRefGoogle Scholar
  17. Maragoudakis, M.E., Tsopanoglou, N.E., Bastaki, M. and Haralabopoulos, G., 1992, Evaluation of promoters and inhibitors of angiogenesis using basement membrane biosynthesis as an index, in: “Angiogenesis in Health and Diseases”, M.E. Maragoudakis, P. Gullino and P. I. Lelkes, eds., Plenum Press, pp. 275.CrossRefGoogle Scholar
  18. Maragoudakis, M.E., Sarmonika M., and Panoutsacopoulou, M., 1988, Inhibition of basement membrane synthesis prevents angiogenesis, J. Pharm. Exp. Therap. 244: 729–733.Google Scholar
  19. Maragoudakis, M.E., Missirlis, E., Sarmonika M., Panoutsacopoulou, M., and Karakiulakis, G., 1990, Basement membrane biosynthesis as a target to tumor therapy, J. Pharm. Exp. Therap. 253: 753–757.Google Scholar
  20. Maragoudakis, M.E., Missirlis, E., Karakiulakis, G.D., Sarmonika, M., Bastaki, M., and Tsopanoglou, N., 1993, Basement membrane biosynthesis as a target for developing inhibitors of angiogenesis with antitumor properties. Kidney Int. 43: 147–150.PubMedCrossRefGoogle Scholar
  21. Maragoudakis, M.E. Angiogenesis. In Annual of Cardiac Surgery, M. Yacoub & J. Pepper (eds), Current Science Ltd. London, pp. 13–19 (1993).Google Scholar
  22. Missirlis, E., Karakiulakis, G., and Maragoudakis, M.E., 1990, Antitumor effects of GPA1734 in rat Walker 256 carcinoma, Invest. New Drugs 8: 145–147.PubMedCrossRefGoogle Scholar
  23. Pipili-Synetos, E., Sakoula, E., & Maragoudakis, M.E., 1993, Nitric oxide is involved in the regulation of angiogenesis. Br. J. Pharmacol. 108: 855–857.PubMedCrossRefGoogle Scholar
  24. Pipili-Synetos, E., Sakoula, E., Haralabopoulos, G., Andricopoulou, P., Peristeris, P. and Maragoudakis, M.E., 1994, Nitric oxide is an endogenous antiangiogenic mediator, Br. J. Pharmacol. (in press).Google Scholar
  25. Powis, G., 1991, Signalling targets for anticancer drug development, TIPS Reviews 12: 188–194.Google Scholar
  26. Rickles, F.R., and Edwards, R.L., 1983, Activation of blood coagulation in cancer: Trousseau’s syndrome revisited, Blood 64: 14–31.Google Scholar
  27. Samuelson, B., Dahlen, S.E., Lindgren, J.A., Rouzel, C.A., and Serhan, C.N., 1987, Leukotriene and lipoxins: structure, biosynthesis and biological effects, Science 237: 1171–1176.CrossRefGoogle Scholar
  28. Tsopanoglou, N.E., Pipili-Synetos, E. and Maragoudakis, M.E., 1993, Protein Kinase C involvement in the regulation of angiogenesis. J. Vascular Research (in press).Google Scholar
  29. Tsopanoglou, N.E., Pipili-Synetos, E., and Maragoudakis, M.E., 1993, Thrombin promotes angiogenesis by a mechanism independent of fibrin formation. Am. J. Physiology (in press).Google Scholar
  30. Tsopanoglou, N.E., Haralabopoulos, G., and Maragoudakis, M.E., 1994, Opposing effects on modulation of angiogenesis by protein kinase C and cyclic-AMPmediated pathways, J. Vascular Res. (in press).Google Scholar
  31. White, C.W., Sondheimer, H.M., Crouch, E.C., Wilson, H., and Fan, L.L., 1989, Treatment of pulmonary hemangimatosis with recombinant interferon alpha-2a, N. Engl. J. Med. 320: 1197–1200.PubMedCrossRefGoogle Scholar
  32. Yamagisawa-Miwa, Uchida, Y., Nakamura, F., Tomaru, T., Kido, H., Kamijo, T., Sugimoto, T., Kaji, K., Utsuyama, M., Kurashima, C. and Ito, H., 1992, Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor, Science 257: 1401–1404.Google Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • M. E. Maragoudakis
    • 1
  • N. E. Tsopanoglou
    • 1
  • G. C. Haralabopoulos
    • 1
  • E. Sakkoula
    • 1
  • E. Pipili-Synetos
    • 1
  • E. Missirlis
    • 1
  1. 1.Department of PharmacologyUniversity of Patras Medical SchoolRio PatrasGreece

Personalised recommendations